The 23rd ADVAC will take at Les Pensières, Annecy, France from8to 19 May 2023.
Registration for the Course is now open and has a closing date of 15 November 2022
ESPID are delighted to offer support to attend the ADVAC course, please note there are only 2 members who will be selected and awarded support based on good standing members points. For more information, Click here
ESPID usually sponsors up to two students who must be ESPID members in good standing
Any ESPID member who wishes to apply for the ADVAC course should register to attend via the ADVAC link here , ESPID members will then be considered for support providing they are in good standing
After an ADVAC selection meeting (February 2023), ESPID members who are in good standing will be selected for support and this is communicated to the individuals sometime there after.
By this statement we, as ESPID board, strongly sympathize with our colleagues from the Ukraine. Children are among the primary victims of armed conflicts and we call on all parties to the conflict in Ukraine to protect our colleagues, children and their families from further violence.
We wholeheartedly hope that all will stay safe the coming time that is filled with fear and uncertainty.
We would like to reach out to the ESPID members from the Ukraine to see if we can offer help in any way. We would like to do whatever we can to support as much as possible in these extremely difficult times. A first request via pTBnet from Vera Chechenyeva (Kiev, Ukraine) to doctors from Poland, Romania, Moldova, Czech, Lithuanian, Latvia: could you, please, be so kind to send your contact data where our refugees can receive TB, ART or any pediatric help:
Name of Institution
Phone number (including country code please)
support you can provide: TB Treatment, Antiretroviral Treatment, Common Pediatrician Help, Psychological, Social
Please send your contact data to the ESPID secretariat: email@example.com and this will be forwarded on and shared with pTBnet.
A webinar on post-COVID-19 condition in children jointly organised by the ECDC and the European Society of Paediatric Infectious Diseases (ESPID) took place on 10 November 2021.
The webinar enabled the sharing of experiences and epidemiological data on post-COVID-19 condition in children between researchers with the aim of shaping future priorities for the condition across Europe.
Participants included members of ESPID, ECDC’s national focal points for COVID-19, and representatives from EU/EEA countries’ National Immunisation Technical Advisory Groups (NITAGs). Presentations from ECDC, Germany, Italy, Finland, and the United Kingdom provided data in the areas of surveillance and epidemiology of post-COVID-19 condition in the paediatric population. The lack of a standardised syndrome definition and harmonised surveillance protocol were highlighted.
The webinar concluded that while challenges remain to identify the burden of post-COVID-19 condition and its consequences in children, some established networks exist. A collaborative approach involving public health specialists and expert groups is essential in responding to these public health challenges. The importance of developing a European network to assist in better understanding the syndrome, its public health consequences, and burden was endorsed. To watch the webinar click below:
A webinar on Multisystem Inflammatory Syndrome in Children (MIS-C) jointly organised by the European Centre for Disease Prevention and Control (ECDC) and the European Society of Paediatric Infectious Diseases (ESPID) took place on 20 January 2022.
The webinar enabled the sharing of experiences and epidemiological data on MIS-C between European researchers, with the aim of shaping future priorities for the condition across Europe.
Participants included members of ESPID, representatives from the World Health Organization (WHO), and focal points for the COVID-19 network at ECDC. Presentations from Sweden, United Kingdom, France, and Spain provided data in several areas of MIS-C.
The lack of a common standardised syndrome definition was highlighted. The webinar concluded that remaining challenges include the appropriate characteristics needed for a standardised case definition due to the lack of large case databases and the multiple phenotypes of children with MIS-C. Nevertheless, the prompt development of a WHO definition at the time the syndrome was first recognised has been an invaluable tool for clinicians and researchers. A collaborative approach involving public health specialists and expert groups is essential in responding to complex public health challenges as in the current COVID-19 pandemic.